Close

News

Global air cargo brand Turkish Cargo chosen as the best air cargo brand of Europe

Global air cargo brand Turkish Cargo chosen as the best air cargo brand of Europe The successful brand of national flag carrier Turkish Airlines, Turkish Cargo is chosen as the best cargo brand of Europe and received “Best Cargo...

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX?CoV2373 is a stable, prefusion protein made using Novavax’ nanoparticle technology...

Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19

Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and selective inhibitor of TRPC6 may alleviate the damage to the lung and decrease the...

aTyr Pharma Announces Research Collaboration with Medical University of South Carolina

aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....

Intec Pharma Announces New Research Collaboration Agreement with MSD

Intec Pharma Ltd. announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential. "We are very excited to continue to work with...

Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research

Thermo Fisher Scientific announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of new pathways and tools to diagnose and better manage transplant patients. The mission of the TIC is...

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

WuXi Biologics, a global company with leading open-access biologics technology platforms, and AB2 Bio Ltd., a Swiss advanced clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, announced that they have entered into a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read